"Paradoxical" immune-mediated reactions to Mycobacterium ulcerans during antibiotic treatment: a result of treatment success, not failure.
about
Mycobacterium ulcerans in the Elderly: More Severe Disease and Suboptimal OutcomesEfficacy of Rifampin Plus Clofazimine in a Murine Model of Mycobacterium ulcerans DiseaseResponse to treatment in a prospective cohort of patients with large ulcerated lesions suspected to be Buruli Ulcer (Mycobacterium ulcerans disease).All-oral antibiotic treatment for buruli ulcer: a report of four patients.A severe case of Buruli ulcer disease with pleural effusionsSecondary Buruli ulcer skin lesions emerging several months after completion of chemotherapy: paradoxical reaction or evidence for immune protection?Clinical features and management of a severe paradoxical reaction associated with combined treatment of Buruli ulcer and HIV co-infection.Severe multifocal form of buruli ulcer after streptomycin and rifampin treatment: comments on possible dissemination mechanisms.Histopathological changes and clinical responses of Buruli ulcer plaque lesions during chemotherapy: a role for surgical removal of necrotic tissue?Successful outcomes with oral fluoroquinolones combined with rifampicin in the treatment of Mycobacterium ulcerans: an observational cohort studySpontaneous clearance of a secondary Buruli ulcer lesion emerging ten months after completion of chemotherapy--a case report from Togo.Corticosteroid use for paradoxical reactions during antibiotic treatment for Mycobacterium ulcerans.Corticosteroid-induced immunosuppression ultimately does not compromise the efficacy of antibiotherapy in murine Mycobacterium ulcerans infection.Phage therapy is effective against infection by Mycobacterium ulcerans in a murine footpad modelMycobacterium ulcerans disease: experience with primary oral medical therapy in an Australian cohort.Incidence, clinical spectrum, diagnostic features, treatment and predictors of paradoxical reactions during antibiotic treatment of Mycobacterium ulcerans infections.Establishment of quantitative PCR (qPCR) and culture laboratory facilities in a field hospital in benin: 1-year results.Impact of human immunodeficiency virus on the severity of buruli ulcer disease: results of a retrospective study in cameroon.Immunohistochemical monitoring of wound healing in antibiotic treated Buruli ulcer patients.Treating Mycobacterium ulcerans disease (Buruli ulcer): from surgery to antibiotics, is the pill mightier than the knife?Local and regional re-establishment of cellular immunity during curative antibiotherapy of murine Mycobacterium ulcerans infectionTreatment Outcome of Patients with Buruli Ulcer Disease in Togo.Buruli-ulcer induced disability in ghana: a study at apromase in the ashanti region.Genetic Susceptibility and Predictors of Paradoxical Reactions in Buruli UlcerAnalysis of Mycobacterium ulcerans-specific T-cell cytokines for diagnosis of Buruli ulcer disease and as potential indicator for disease progression.Multifocal Buruli Ulcer Associated with Secondary Infection in HIV Positive Patient.Clinical and bacteriological efficacy of rifampin-streptomycin combination for two weeks followed by rifampin and clarithromycin for six weeks for treatment of Mycobacterium ulcerans disease.Increasing Experience with Primary Oral Medical Therapy for Mycobacterium ulcerans Disease in an Australian Cohort.Post Liposuction Mycobacterium Abscessus Surgical Site Infection in a Returned Medical tourist Complicated by a Paradoxical Reaction During Treatment.Wound healing: Natural history and risk factors for delay in Australian patients treated with antibiotics for Mycobacterium ulcerans disease.Shorter-course treatment for Mycobacterium ulcerans disease with high-dose rifamycins and clofazimine in a mouse model of Buruli ulcerBuruli Ulcer: a Review of the Current Knowledge
P2860
Q28551237-BE400580-993F-462A-B6BF-B69B9BFEE942Q28552524-57B197C9-A57E-4646-9B4B-037658455FA5Q33631299-D2DE9D75-6F33-4001-B95D-AA1ADFA57CCDQ33769921-0FD510EF-1115-49E7-BF66-A2926AFBAB77Q33778730-15AEB01A-DCF1-4E23-AF50-D039E0469FA5Q33988898-C80A203D-748F-46F6-96C3-A0163DB8DEDFQ34006790-5B4E5517-5061-4200-8ED8-FF1F56A47494Q34024822-64027670-7AF0-46A0-B58F-6F2E6B51DBB2Q34043539-A0AB3BD5-D9FC-43A2-8E44-5207A1CEE3B3Q34137837-D6927AC5-4D44-425D-A293-373021388323Q34364979-CFDA5391-EC3F-4359-A3D7-F3D2CDECD12BQ34431496-94793DEB-FA38-4759-A8FB-BD9AE12387EDQ34500901-1C488301-9720-4EC6-91C9-9B26C663346BQ34702499-673F079F-4CC9-4191-BB3B-AC507974E300Q34855365-CE7D8587-4D5F-435A-96C2-531FEFD0F245Q34978950-BD6146FD-4E42-4DEB-BDA3-DC62AECF065FQ35036322-928E94BF-D066-4D63-9320-350705647369Q35071988-260A7CDB-FCC5-4AD1-BE3A-0F7B97FD7247Q35156761-72B31647-C945-474F-90CF-DAEFC177B432Q35625819-92D55487-1E19-4784-A221-4FDF9B526A54Q35790836-6F8A7B9E-AAFB-4238-B390-FC4251507A4DQ35810457-F312C315-6775-410D-A484-8775C88FCAE1Q35993770-4B3B7273-39CE-473F-B26A-7C892E162B5AQ35994923-EE1E7560-1C15-441B-AC82-0B0DB9681EF5Q36291527-71B512CA-2BCE-432F-B4A7-6393798C8148Q37457023-CB3E1756-EB66-4B52-AE7D-EA4112091275Q37544684-0D3865A1-B7EE-493A-8867-AE1D74186AC0Q40789030-4FBEF8B7-9D0A-45E4-B20C-0A9BEA24D043Q40837652-CAE0DBC1-9A01-4591-B214-53152DABE95CQ51738497-D0C48AD1-A227-4B75-B4DC-F6206F1E8BF2Q58785246-AB1DABFF-F41A-4575-B900-54D62096ACBEQ59132198-FB53B59D-7E50-448F-BFEC-A1A3C665E260
P2860
"Paradoxical" immune-mediated reactions to Mycobacterium ulcerans during antibiotic treatment: a result of treatment success, not failure.
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
"Paradoxical" immune-mediated ...... reatment success, not failure.
@ast
"Paradoxical" immune-mediated ...... reatment success, not failure.
@en
"Paradoxical" immune-mediated ...... reatment success, not failure.
@nl
type
label
"Paradoxical" immune-mediated ...... reatment success, not failure.
@ast
"Paradoxical" immune-mediated ...... reatment success, not failure.
@en
"Paradoxical" immune-mediated ...... reatment success, not failure.
@nl
prefLabel
"Paradoxical" immune-mediated ...... reatment success, not failure.
@ast
"Paradoxical" immune-mediated ...... reatment success, not failure.
@en
"Paradoxical" immune-mediated ...... reatment success, not failure.
@nl
P2093
P1476
"Paradoxical" immune-mediated ...... treatment success, not failure
@en
P2093
Anthony H McDonald
Daniel P O'Brien
Michael E Robson
Peter P Callan
P304
P407
P577
2009-11-01T00:00:00Z